Compounds > 5-(tetradecyloxy)-2-furancarboxylic acid
Page last updated: 2024-09-03

5-(tetradecyloxy)-2-furancarboxylic acid and Hepatocellular Carcinoma

5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benoist, F; Grand-Perret, T1

Other Studies

1 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and Hepatocellular Carcinoma

ArticleYear
ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools.
    Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:10

    Topics: Apolipoproteins B; Carcinoma, Hepatocellular; Enzyme Inhibitors; Furans; Humans; Hypolipidemic Agents; Lipid Metabolism; Lovastatin; Simvastatin; Triglycerides; Tumor Cells, Cultured

1996